US20110281798A1 - Methods for Lowering Plasma Glucagon with Exendins and Exendin Agonist Analogs - Google Patents

Methods for Lowering Plasma Glucagon with Exendins and Exendin Agonist Analogs Download PDF

Info

Publication number
US20110281798A1
US20110281798A1 US13/045,334 US201113045334A US2011281798A1 US 20110281798 A1 US20110281798 A1 US 20110281798A1 US 201113045334 A US201113045334 A US 201113045334A US 2011281798 A1 US2011281798 A1 US 2011281798A1
Authority
US
United States
Prior art keywords
xaa
exendin
ala
gly
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/045,334
Inventor
Orville G. Kolterman
Andrew A. Young
James J. L'Italien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amylin Pharmaceuticals LLC
Original Assignee
Amylin Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US11638099P priority Critical
Priority to US13201799P priority
Priority to US17536500P priority
Priority to US17526500P priority
Priority to US09/889,331 priority patent/US6872700B1/en
Priority to PCT/US2000/000942 priority patent/WO2000041548A2/en
Priority to US11/083,730 priority patent/US7153825B2/en
Priority to US11/272,488 priority patent/US7399489B2/en
Priority to US12/100,880 priority patent/US20080249018A1/en
Priority to US12/389,509 priority patent/US7906146B2/en
Priority to US13/045,334 priority patent/US20110281798A1/en
Application filed by Amylin Pharmaceuticals LLC filed Critical Amylin Pharmaceuticals LLC
Assigned to AMYLIN PHARMACEUTICALS, INC. reassignment AMYLIN PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: L'ITALIEN, JAMES L., YOUNG, ANDREW, KOLTERMAN, ORVILLE G.
Assigned to ELI LILLY AND COMPANY reassignment ELI LILLY AND COMPANY SECURITY AGREEMENT Assignors: AMYLIN PHARMACEUTICALS, INC.
Publication of US20110281798A1 publication Critical patent/US20110281798A1/en
Assigned to AMYLIN PHARMACEUTICALS, INC. reassignment AMYLIN PHARMACEUTICALS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: ELI LILLY AND COMPANY
Assigned to AMYLIN PHARMACEUTICALS, LLC reassignment AMYLIN PHARMACEUTICALS, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: AMYLIN PHARMACEUTICALS, INC.
Assigned to ASTRAZENECA PHARMACEUTICALS, LP reassignment ASTRAZENECA PHARMACEUTICALS, LP AMYLIN PHARMACEUTICALS, LLC ASSIGNS AN EQUAL AND UNDIVIDED ONE-HALF OF ITS ENTIRE RIGHT, TITLE AND INTEREST TO ASTRAZENECA PHARMACEUTICALS LP Assignors: AMYLIN PHARMACEUTICALS, LLC
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46323143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20110281798(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application status is Abandoned legal-status Critical

Links